Oxidative stress and Parkinson’s disease: New hopes in treatment with herbal antioxidants

Current Pharmaceutical Design

Volumn 22, Issue 2, 2015, Pages 238-246

  Sarrafchi, Amir ^a   Bahmani, Mahmoud ^b   Shirzad, Hedayatollah ^a   Rafieian Kopaei, Mahmoud ^a  

^a SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antioxidant; Degenerative disorder; Herbal medicines; Medicinal plants; Oxidative stress; Parkinson's disease

Indexed keywords

ANTIOXIDANT; NEUROPROTECTIVE AGENT;

HUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PHYTOTHERAPY;

ANTIOXIDANTS; HUMANS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PARKINSON DISEASE; PHYTOTHERAPY;

EID: 84951815655     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612822666151112151653     Document Type: Review

References (138)

1. Bagetta V, Sgobio C, Pendolino V, et al. Rebalance of striatal NMDA/AMPA receptor ratio underlies the reduced emergence of dyskinesia during D2-like dopamine agonist treatment in experimental Parkinson’s disease. J Neurosci 2012; 32: 17921-31.
2. Gazewood JD, Richards DR, Clebak K. Parkinson disease: an update. Am Fam Phys 2013; 87: 267-73.
3. Rao SS, Hofmann LA, Shakil A. Parkinson’s disease: diagnosis and treatment. Am Fam Phys 2006; 74: 2046-54.
4. Blandini F. Neural and immune mechanisms in the pathogenesis of Parkinson’s disease. J Neuroimmune Pharmacol 2013; 8: 189-201.
5. Jafari S, Etminan M, Aminzadeh F, Samii A. Head injury and risk of Parkinson disease: A systematic review and metaanalysis. Mov Disord 2013; 28: 1222-9.
6. Blandini F. Neural and immune mechanisms in the pathogenesis of Parkinson’s disease. J Neuroimmune Pharmacol 2013; 8, 189-201.
7. Li F, Zhu S, Wu C, Yan C, Liu Y, Shugan L. Neuroin-ammation and cell therapy for Parkinson’s disease. Front Biosci 2011; 3, 1407-20.
8. Yan MH, Wang X, Zhu X. Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease. Free Radic Biol Med 2013; 62: 90-101.
9. Rabiei Z, Rafieian-Kopaei M. Neuroprotective effect of pretreatment with Lavandula officinalis ethanolic extract on bloodbrain barrier permeability in a rat stroke model. Asian Pacif J Trop Med 2014; 7: S421-S6.
10. Lindvall O. Developing dopaminergic cell therapy for Parkinson’s disease-give up or move forward? Mov Disord 2013; 28: 268-73.
11. Scovassi IA. Parkinson’s disease: New insights. Biochem Pharmacol 2013; 2: 3.
12. Jayaraj RL. An Overview of Parkinson's Disease and Oxidative Stress: Herbal Scenario. Neuropathol Dis 2012; 1(2): 95-122.
13. Blandin F. Neural and immune mechanisms in the pathogenesis of Parkinson’s disease. J Neuroimmune Pharmacol 2013; 8: 189-201.
14. Beal MF. Mitochondria and neurodegeneration. Novartis Found Symp 2007; 287: 183-92.
15. Greenamyre JT, Hastings TG. Biomedicine. Parkinson’s-divergent causes, convergent mechanisms. Science 2004; 304: 20-1122.
16. Hwang O. Role of Oxidative Stress in Parkinson’s disease. Exp Neurobiol 2013; 22(1): 11-7
17. Rafieian-Kopaei M, Nasri H. Re: Erythropoietin ameliorates oxidative stress and tissue injury following renal ischemia/reperfusion in rat kidney and lung. Med Princ Pract 2014; 23(1): 95.
18. Baradaran A, Nasri H, Rafieian-Kopaei M. Comment on: Antioxidative stress activity of Stachys lavandulifolia aqueous extract in humans. Cell J 2013; 15(3): 272-3.
19. Baradaran A, Nasri H, Rafieian-Kopaei M. Oxidative stress and hypertension: Possibility of hypertension therapy with antioxidants. J Res Med Sci 2014; 19(4): 358-67.
20. Green DR, Kroemer G. The pathophysiology of mitochondrial cell death. Science 2004; 305: 626-9.
21. Weisskopf MG, O'reilly E, Chen H. Plasma urate and risk of Parkinson’s disease. Am J Epidemiol 2007; 166: 561-7.
22. Van Laar VS, Mishizen AJ, Cascio M, et al. Proteomic identification of dopamine-conjugated proteins from isolated rat brain mitochondria and SH-SY5Y cells. Neurobiol Dis 2009; 34: 487-500.
23. Conway KA, Rochet JC, Bieganski RM, Lansbury PT. Kinetic stabilization of the alpha-synuclein protofibril by a dopaminealpha-synuclein adduct. Science 2001; 294: 1346-9.
24. Qu W, Fan L, Kim YC, Kaempferol derivatives prevent oxidative stress-induced cell death in a DJ-1-dependent manner. J Pharmacol Sci 2009; 110: 191-200.
25. Zafar KS, Inayat-Hussain SH, Ross D. A comparative study of proteasomal inhibition and apoptosis induced in N27 mesencephalic cells by dopamine and MG132. J Neurochem 2007; 102: 913-21.
26. Zecca L, Wilms H, Geick S, et al. Human neuromelanin induces neuro-inflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson’s disease. Acta Neuropathol 2008; 116: 47-55.
27. Rabinovic AD, Lewis DA, Hastings TG. Role of oxidative changes in the degeneration of dopamine terminals after injection of neurotoxic le vels of dopamine. Neuroscience 2000; 101: 67-76.
28. Beal MF. Mitochondrial dysfunction and oxidative damage in Alzheimer’s and Parkinson’s diseases and coenzyme Q10 as a potential treatment. J Bioenerg Biomembr 2004; 36: 381-6
29. Shults CW. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol 2002; 59: 1541-50.
30. Lu KT. Neuroprotective effects of resveratrol on MPTP-induced neuron loss mediated by free radical scavenging. J Agric Food Chem 2008; 56: 6910-3.
31. Shirzad H, Taji F, Rafieian-Kopaei M. Correlation between antioxidant activity of garlic extracts and WEHI-164 fibrosarcoma tumor growth in BALB/c mice. J Med Food 2011; 14(9): 969-74.
32. Shirzad H, Shahrani M, Rafieian-Kopaei M. Comparison of morphine and tramadol effects on phagocytic activity of mice peritoneal phagocytes in vivo. Int Immunopharmacol 2009; 9(7-8): 968-70.
33. Bahmani M, Zargaran A, Rafieian-Kopaei M, Saki M. Ethnobotanical study of medicinal plants used in the management of diabetes mellitus in the Urmia, Northwest Iran. Asian Pac J Trop Med 2014; 7(Suppl 1): 348-54.
34. Mirhoseini M, Baradaran A, Rafieian-Kopaei M. Medicinal plants, diabetes mellitus and urgent needs. J Herbmed Pharmacol 2013; 2(2): 53-4.
35. Rafieian-Kopaei M, Shahinfard N, Rouhi-Boroujeni H, et al. Effects of Ferulago angulata extract on serum lipids and lipid peroxidation. Evid-Base Compl Alternat Med 2014; 2014: 680856.
36. Mirhosseini M, Baradaran A, Rafieian-Kopaei M. Anethum graveolens and hyperlipidemia: A randomized clinical trial. J Res Med Sci 2014; 19: 758-61.
37. Bahmani M, Zargaran A, Rafieian-Kopaei M. Identification of medicinal plants of Urmia for treatment of gastrointestinal disorders. Rev Bras Farmacogn 2014; 24: 468-48.
38. Bahmani M, Rafieian-Kopaei M, Hassanzadazar H, Saki K, Karamati SA, Delfan B. A review on most important herbal and synthetic antihelmintic drugs. Asian Pacific J Trop Med 2014; 7(Suppl 1): 29-33.
39. Saki K, Bahmani M, Rafieian-Kopaei M. The effect of most important medicinal plants on two important psychiatric disorders (anxiety and depression)-a review. Asian Pac J Trop Med 2014; 7(Suppl 1): 34-42.
40. Bahmani M, Shirzad HA, Majlesi M, Shahinfard N, Rafieian-Kopaei M. A review study on analgesic applications of Iranian medicinal plants. Asian Pacific J Trop Med 2014; 7(Suppl 1): 43-53.
41. Henchcliffe C, Beal MF. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neurol 2008; 4(11): 600-9.
42. Rabiei Z, Rafieian-kopaei M, Heidarian E, Saghaei E, Mokhtari S. Effects of zizyphus jujube extract on memory and learning impairment induced by bilateral electric lesions of the nucleus basalis of meynert in rat. Neurochem Res 2014; 39(2): 353-60.
43. Delfan B, Bahmani M, Hassanzadazar H, Saki K, Rafieian-Kopaei M. Identification of medicinal plants affecting on headaches and migraines in Lorestan Province, West of Iran. Asian Pacific J Trop Med 2014; 7(Suppl 1): 376-9.
44. Asadi-Samani M, Bahmani M, Rafieian-Kopaei M. The chemical composition, botanical characteristic and biological activities of Borago officinalis: a review. Asian Pacific J Trop Med 2014; 7(Suppl 1): 22-8.
45. Liu SM, Li XZ, Huo Y, Lu F. Protective effect of extract of Acanthopanax senticosus Harms on dopaminergic neurons in Parkinson's disease mice. Phytomedicine 2012; 19: 631-8.
46. Lahaie-Collins V, Bournival J, Plouffe M, Carange J, Martinoli MG. Sesamin modulates tyrosine hydroxylase, superoxide dismutase, catalase, inducible NO synthase and interleukin-6 expression in dopaminergic cells under MPP+-induced oxidative stress. Oxid Med Cell Longevity 2008; 1: 54-62.
47. Asgari S, Setorki M, Rafieian-kopaei M, et al. Postprandial hypolipidemic and hypoglycemic effects of Allium hertifolium and Sesamum indicum on hypercholesterolemic rabbits. Afr J Pharm Pharmacol.2012; 6(15): 1131-5.
48. Zhang ZJ, Cheang LC, Wang MW, et al. Ethanolic extract of fructus Alpinia oxyphylla protects against 6-hydroxydopamineinduced damage of PC12 cells in vitro and dopaminergic neurons in zebrafish. Cell Mol Neurobiol 2012; 32: 27-40.
49. An LJ, Guan S, Shi GF, Bao YM, Duan YL, Jiang B. Protocatechuic acid from Alpinia oxyphylla against MPP+-induced neurotoxicity in PC12 cells. Food Chem Toxicol 2006; 44: 436-43.
50. Zhang ZG, Wu L, Wang JL, et al. Astragaloside IV prevents MPP(+)-induced SH-SY5Y cell death via the inhibition of Baxmediated pathways and ROS production. Mol Cell Biochem 2012; 364: 209-16.
51. LI WX, Sun SG, Yuan H, Wang HT, Zhang YB, Sun BL. Time dependency of astragalus polysaccharides against systemic injury of free radical in astrocyte culture medium. Chin J Clin Rehabil 2006; 10: 56-61.
52. Tanaka K, Miyake Y, Fukushima W, et al. Intake of Japanese and Chinese teas reduces risk of Parkinson's disease. Parkinsonism Relat Disord 2011; 17: 446-50.
53. Guo S, Yan J, Yang T, Yang X, Bezard E, Zhao B. Protective effects of green tea polyphenols in the 6-OHDA rat model of Parkinson's disease through inhibition of ROS-NO pathway. Biol Psychiatry 2007; 62: 1353-62.
54. Li R, Peng N, Li XP, Le WD. (-)-Epigallocatechin gallate regulates dopamine transporter internalization via protein kinase Cdependent pathway. Brain Res 2006; 1097: 85-9.
55. Choi JY, Park CS, Kim DJ, et al. Prevention of nitric oxidemediated 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced Parkinson's disease in mice by tea phenolic epigallocatechin 3-gallate. Neurotoxicology 2002; 23: 367-74.
56. Kim JS, Kim JM, O JJ, Jeon BS. Inhibition of inducible nitric oxide synthase expression and cell death by (-)-epigallocatechin-3-gallate, a green tea catechin, in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinson's disease. J Clin Neurosci 2010; 17: 1165-8.
57. Asadi SY, Parsaei P, Karimi M, et al. Effect of green tea (Camellia sinensis) extract on healing process of surgical wounds in rat. Int J Surg 2013; 11(4): 332-7.
58. Asadi Y, Karimi M, Parsaei P, et al. Effects of camellia sinensis ethanolic extract on histometric and histopathological healing process of burn wound in rat. Middle-East J Sci Res 2013; 13 (1): 14-9.
59. Ju MS, Kim HG, Choi JG, et al. Cassiae semen, a seed of Cassia obtusifolia, has neuroprotective effects in Parkinson's disease models. Food Chem Toxicol 2010; 48: 2037-44.
60. Shin BY, Kim DH, Hyun SK, et al. Alaternin attenuates delayed neuronal cell death induced by transient cerebral hypoperfusion in mice. Food Chem Toxicol 2010; 48: 1528-36.
61. Kim IS, Koppula S, Park PJ, et al. Chrysanthemum morifolium Ramat (CM) extract protects human neuroblastoma SH-SY5Y cells against MPP+-induced cytotoxicity. J Ethnopharmacol 2009; 126: 447-54.
62. Kim IS, Ko HM, Koppula S, Kim BW, Choi DK. Protective effect of Chrysanthemum indicum Linne against 1-methyl-4-phenylpridinium ion and lipopolysaccharide-induced cytotoxicity in cellular model of Parkinson's disease. Food Chem Toxicol 2011; 49: 963-73.
63. Li WW, Yang R, Cai DF. Protective effects of Cistanche total glycosides on dopaminergic neuron in substantia nigra of model mice of Parkinson's disease. Zhongguo Zhong Xi Yi Jie He Za Zhi 2008; 28: 248-51.
64. Zhao Q, Gao J, Li W, Cai D. Neurotrophic and neurorescue effects of echinacoside in the subacute MPTP mouse model of Parkinson's disease. Brain Res 2010; 1346: 224-36.
65. Gao Y, Pu XP. Neuroprotective effect of acteoside against rotenoneinduced damage of SH-SY5Y cells and its possible mechanism. Chin Pharmacol Bull 2007; 23: 161-5.
66. Li ZG, Jiang B, Bao YM, An LJ. Protection of Semen Cuscuta extracts from apoptosis PC12 cell of induced by1-methyl-4-phenylpyridinium. Chin Tradit Pat Med 2006; 28: 219-21.
67. Langley D. Exploiting the fungi: novel leads to new medicines. Mycologist 1998; 11: 165-6.
68. Komarova EL, Tolkachev ON. The chemistry of peptide ergot alkaloids. Pharm Chem J 2001; 35: 504-6.
69. Robinson SL, Panaccione DG. Heterologous expression of lysergic acid and novel ergot alkaloids in aspergillus fumigatus. Appl Environ Microbiol 2014; 80(20): 6465-72.
70. Molina-Jimenez MF, Sanchez-Reus MI, Andres D, Cascales M, Benedi J. Neuroprotective effect of fraxetin and myricetin against rotenone-induced apoptosis in neuroblastoma cells. Brain Res 2004; 1009: 9-16.
71. Zhao DL, Zou LB, Lin S, Shi JG, Zhu HB. Anti-apoptotic effect of esculin on dopamine-induced cytotoxicity in the human neuroblastoma SH-SY5Y cell line. Neuropharmacology 2007; 53: 724-32.
72. Zhao DL, Shi L, Zhai KG, et al. Esculin, an extract from Fraxinus sielboldiana blume, protects SH-SY5Y cells fromMPP+-induced cytotoxicity. Acad J PLA Postgrad Med Sch 2008; 29: 112-4.
73. An H, Kim IS, Koppula S, et al. Protective effects of Gastrodia elata Blume on MPP+-induced cytotoxicity in human dopaminergic SH-SY5Y cells. J Ethnopharmacol 2010; 130: 290-8.
74. Kim IS, Choi DK, Jung HJ. Neuroprotective effects of vanillyl alcohol in Gastrodia elata Blume through suppression of oxidative stress and anti-apoptotic activity in toxin-induced dopaminergic MN9D cells. Molecules 2011; 16: 5349-61.
75. In-Ho B, Seung-Ho SO. The world ginseng market and the ginseng. J Ginseng Res 2013; 37(1): 1-6.
76. Mahady GB, Gyllenhall C, Fong HH, Farnsworth NR. Ginsengs: a review of safety and efficacy. Nutr Clin Care 2000; 3: 90-101.
77. Kaneko H. Proof of the mysterious efficacy of ginseng: basic and clinical trials: clinical effects of medical ginseng, Korean red gin seng: specifically, its anti-stress action for prevention of disease. J Pharmacol Sci 2004; 95(2): 158-62.
78. Wang P, Niu L, Guo XD, et al. Gypenosides protects dopaminergic neurons in primary culture against MPP(+)-induced oxidative injury. Brain Res Bull 2010; 83: 266-71.
79. Wang P, Niu L, Gao L, et al. Neuroprotective effect of gypenosides against oxidative injury in the substantia nigra of a mouse model of Parkinson's disease. J Int Med Res 2010; 38: 1084-92.
80. Mohanasundari M, Sabesan M. Modulating effect of Hypericum perforatum extract on astrocytes in MPTP induced Parkinson's disease in mice. Eur Rev Med Pharmacol Sci 2007; 11: 17-20.
81. Lu YH, Du CB, Liu JW, Hong W, Wei DZ. Neuroprotective effects of Hypericum perforatum on trauma induced by hydrogen peroxide in PC12 cells. Am J Chin Med 2004; 32: 397-405.
82. Zou YP, Lu YH, Wei DZ. Protective effects of a flavonoid-rich extract of Hypericum perforatum L.against hydrogen peroxide induced apoptosis in PC12 cells. Phytother Res 2010; 24(Suppl 1): S6-S10.
83. Wang DQ, Wang W, Jing FC, Zhao JN. Effects of tetramethylpyrazine on the extracellular DA, its metabolites and hydroxyl radical in striatum of PD rats treated by L-DOPA. Chin Pharm J 2007; 42: 28-32.
84. Du J, Shan LC, Zhang GX, Wang YQ. Effect of TMP on dopaminergic neuron injury induced by MPTP in vivo and in vitro. Lishizhen Med Mater Med Res 2011; 22: 1564-5.
85. Verma DM, Balakrishnan NP., Dixit RD. Flora of Madhya Pradesh. Botanical Survey of India. Lucknow, India 1993.
86. Pruriens M. Research Update. Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study. J Neurol Neurosurg Psychiatry 2004; 75(12): 1672-7.
87. Manyam BV, Dhanasekaran M, Hare TA. Effect of antiparkinson drug HP-200 (Mucuna pruriens) on the central monoaminergic neurotransmitters. Phytother Res 2004; 18(2): 97-101.
88. Liu DZ, Zhu J, Jin DZ, et al. Behavioral recovery following subchronic paeoniflorin administration in the striatal 6-OHDA lesion rodent model of Parkinson's disease. J Ethnopharmacol 2007; 112: 327-32.
89. Cao BY, Yang YP, Luo WF, et al. Paeoniflorin, a potent natural compound, protects PC12 cells from MPP+ and acidic damage via autophagic pathway. J Ethnopharmacol 2010; 131: 122-9.
90. Liu HQ, Zhang WY, Luo XT, Ye Y, Zhu XZ. Paeoniflorin attenuates neuroinflammation and dopaminergic neurodegeneration in the MPTP model of Parkinson's disease by activation of adenosine A1 receptor. Br J Pharmacol 2006; 148: 314-25.
91. Choi JG, Kim HG, Kim MC, et al. Polygalae radix inhibits toxininduced neuronal death in the Parkinson's disease models. J Ethnopharmacol 2011; 134: 414-21.
92. Liang Z, Shi F, Wang Y, Lu L, Zhang Z, Wang X. Neuroprotective effects of tenuigenin in a SH-SY5Y cell model with 6-OHDAinduced injury. Neurosci Lett 2011; 497: 104-9.
93. Yuan HL, Li B, Xu J, et al. Tenuigenin protects dopaminergic neurons from inflammation-mediated damage induced by the lipopolysaccharide. CNS Neurosci Ther 2012; 18: 584-90.
94. Jeong JK, Moon MH, Bae BC, et al. Autophagy induced by resveratrol prevents human prion protein-mediated neurotoxicity. Neurosci Res 2012; 73: 99-105.
95. Bournival J, Quessy P, Martinoli MG. Protective effects of resveratrol and quercetin against MPP+-induced oxidative stress act by modulating markers of apoptotic death in dopaminergic neurons. Cell Mol Neurobiol 2009; 29: 1169-80.
96. Srivastava G, Dixit A, Yadav S, Patel DK, Prakash O, Singh MP. Resveratrol potentiates cytochrome P450 2 d22-mediated neuroprotection in maneb-and paraquat-induced Parkinsonism in the mouse. Free Radic Biol Med 2012; 52: 1294-306.
97. Jin F, Wu Q, Lu YF, Gong QH, Shi JS. Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats. Eur J Pharmacol 2008; 600: 78-82.
98. Chao J, Li H, Cheng KW, Yu MS, Chang RC, Wang M. Protective effects of pinostilbene, a resveratrol methylated derivative, against 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells. J Nutr Biochem 2010; 21: 482-9.
99. hao G, Li S, Qin GW, Fei J, Guo LH. Inhibitive effects of Fructus Psoraleae extract on dopamine transporter and noradrenaline transporter. J Ethnopharmacol 2007; 112: 498-506.
100. Zhao G, Zang SY, Zheng XW, Zhang XH, Guo LH. Bakuchiol analogs inhibit monoamine transporters and regulate monoaminergic functions. Biochem Pharmacol 2008; 75: 1835-47.
101. Zhu G, Wang X, Wu S, Li Q. Involvement of activation of PI3K/Akt pathway in the protective effects of puerarin against MPP+-induced human neuroblastoma SH-SY5Y cell death. Neurochem Int 2012; 60: 400-8.
102. Zhu G, Wang X, Chen Y, et al. Puerarin protects dopaminergic neurons against 6-hydroxydopamine neurotoxicity via inhibiting apoptosis and upregulating glial cell line-derived neurotrophic factor in a rat model of Parkinson's disease. Planta Med 2010; 76: 1820-6.
103. Li X, Ye X, Sun X, et al. Salidroside protects against MPP(+)-induced apoptosis in PC12 cells by inhibiting the NO pathway. Brain Res 2011; 1382: 9-18.
104. Wang XJ, Xu JX. Salvianic acid A protects human neuroblastoma SH-SY5Y cells against MPP+ induced cytotoxicity. Neurosci Res 2005; 51: 129-38.
105. Zhang HA, Gao M, Zhang L, et al. Salvianolic acid A protects human SH-SY5Y neuroblastoma cells against H2O2 induced injury by increasing stress tolerance ability. Biochem Biophys Res Commun 2012; 421: 479-83.
106. Tian LL, Wang XJ, Sun YN, et al. Salvianolic acid B, an antioxidant from Salvia miltiorrhiza, prevents 6hydroxydopamine induced apoptosis in SH-SY5Y cells. Int J Biochem Cell Biol 2008; 40: 409-22.
107. Mu X, He G, Cheng Y, Li X, Xu B, Du G. Baicalein exerts neuroprotective effects in 6 hydroxydopamine-induced experimental Parkinsonism in vivo and in vitro. Pharmacol Biochem Behav 2009; 92: 642-8.
108. Li XX, He GR, Mu X, et al. Protective effects of baicalein against rotenone-induced neurotoxicity in PC12 cells and isolated rat brain mitochondria. Eur J Pharmacol 2012; 674: 227-33.
109. Choi JH, Choi AY, Yoon H, et al. Baicalein protects HT22 murine hippocampal neuronal cells against endoplasmic reticulum stressinduced apoptosis through inhibition of reactive oxygen species production and CHOP induction. Exp Mol Med 2010; 42: 811-22.
110. Mu X, He GR, Yuan X, Li XX, Du GH. Baicalein protects the brain against neuron impairments induced by MPTP in C57BL/6 mice. Pharmacol Biochem Behav 2011; 98: 286-91.
111. Li FQ, Wang T, Pei Z, Liu B, Hong JS. Inhibition of microglial activation by the herbal flavonoid baicalein attenuates inflammation-mediated degeneration of dopaminergic neurons. J Neural Transm 2005; 112: 331-47.
112. Liu Y, Chen HL, Yang G. Extract of Tripterygium wilfordii Hook F protect dopaminergic neurons against lipopolysaccharide-induced inflammatory damage. Am J Chin Med 2010; 38: 801-14.
113. Li FQ, Cheng XX, Liang XB, et al. Neurotrophic and neuroprotective effects of tripchlorolide, an extract of Chinese herb Tripterygium wilfordii Hook F, on dopaminergic neurons. Exp Neurol 2003; 179: 28-37.
114. Xue B, Jiao J, Zhang L, et al. Triptolide upregulates NGF synthesis in rat astrocyte cultures. Neurochem Res 2007; 32: 1113-9.
115. Rabey JM, Vered Y, Shabtai H, Graff E, Harsat A, Korczyn AD. Broad bean (Vicia faba) consumption and Parkinson's disease. Adv Neurol 1993; 60: 681-4.
116. Baginsky C, Peña-Neira A, Cáceres A. et al. Phenolic compound composition in immature seeds of fava bean (Vicia faba L.) varieties cultivated in Chile. J Food Compost Anal 2013; 31(1): 1-6.
117. Essa MM, Braidy N, Bridge W. et al. Review of natural products on parkinson’s disease pathology. J Aging Res Clin Pract 2014; 3(1): 1-8.
118. Martinez-Vicente M, Talloczy Z, Kaushik S, et al. Dopaminemodified alpha-synuclein blocks chaperone-mediated autophagy. J Clin Invest 2008; 118: 777-88.
119. Conway KA, Rochet JC, Bieganski RM, Lansbury PT. Kinetic stabilization of the alpha-synuclein protofibril by a dopaminealpha-synuclein adduct. Science 2001; 294: 1346-9.
120. Ghasemi-Pirbaluti M, Pourgheysari B, Shirzad H, et al. Effect of Epigallocatechin-3-gallate (EGCG) on cell proliferation inhibition and apoptosis induction in lymphoblastic leukemia cell line. J Herbmed Pharmacol 2015; 4(2): 65-8.
121. Shirzad H, Kiani M, Shirzad M. Impacts of tomato extract on the mice fibrosarcoma cells. J Herbmed Pharmacol 2013; 2(1): 13-6.
122. Behradmanesh S, Horestani MK, Baradaran A, Nasri H. Association of serum uric acid with proteinuria in type 2 diabetic patients. J Res Med Sci 2013; 18: 44-6.
123. Rafieian-Kopaei M, Nasri H. The Ameliorative effect of Zingiber officinale in diabetic nephropathy. Iran Red Crescent Med J 2014 May; 16(5): e11324.
124. Asgary S, Kelishadi R, Rafieian-Kopaei M, Najafi S, Najafi M, Sahebkar A. Investigation of the lipid-modifying and antiinflammatory effects of Cornus mas L. supplementation on dyslipidemic children and adolescents. Pediatr Cardiol 2013; 34(7): 1729-35.
125. Asgary S, Rafieian-Kopaei M, Shamsi F, Najafi S, Sahebkar A. Biochemical and histopathological study of the anti-hyperglycemic and anti-hyperlipidemic effects of cornelian cherry (Cornus mas L.) in alloxan-induced diabetic rats. J Complement Integr Med 2014; 11(2): 63-9.
126. Rahimian G, Sanei MH, Shirzad H, et al. Virulence factors of Helicobacter pylori vacA increase markedly gastric mucosal TGF-β1 mRNA expression in gastritis patients. Microb Pathog 2014; 67-68: 1-7.
127. Bahmani M, Rafieian-Kopaei M, Hassanzadazar H, Saki K, Karamati SA, Delfan B. A review on most important herbal and synthetic antihelmintic drugs. Asian Pacific J Trop Med 2014; 7(Suppl 1): 29-33.
128. Taghikhani A, Afrough H, Ansari-Samani R, Shahinfard N, Rafieian-Kopaei M. Assessing the toxic effects of hydroalcoholic extract of Stachys lavandulifolia Vahl on rat's liver. Bratisl Lek Listy 2014; 115(3): 121-4.
129. Heidarian E, Rafieian-Kopaei M. Protective effect of artichoke (Cynara scolymus) leaf extract against lead toxicity in rat. Pharm Biol 2013; 51(9): 1104-9.
130. Nasri H, Rafieian-Kopaei M. Protective effects of herbal antioxidants on diabetic kidney disease. J Res Med Sci 2014; 19(1): 82-3.
131. Baradaran A, Nasri H, Nematbakhsh M, Rafieian-Kopaei M. Antioxidant activity and preventive effect of aqueous leaf extract of Aloe Vera on gentamicin-induced nephrotoxicity in male Wistar rats. Clin Ter 2014; 165(1): 7-11.
132. Nasri H, Rafieian-Kopaei M. Medicinal plants and antioxidants: Why they are not always beneficial? Iranian J Public Health 2014; 43(2): 255-7.
133. Rafieian-Kopaei M, Baradaran A, Rafieian M. Oxidative stress and the paradoxical effects of antioxidants. J Res Med Sci 2013; 18(7): 628.
134. Offen D, Ziv I, Sternin H, Melamed E, Hochman A. Prevention of dopamine-induced cell death by thiol antioxidants: possible implications for treatment of Parkinson's disease. Exp Neurol 1996; 141(1): 32-9.
135. Asadbeigi M, Mohammadi T, Rafieian-Kopaei M, Saki K, Bahmani M, Delfan B. Traditional effects of medicinal plants in the treatment of respiratory diseases and disorders: an ethnobotanical study in the Urmia. Asian Pac J Trop Med 2014; 7(Suppl 1): S364-8.
136. Parsaei P, Karimi M, Asadi SY, Rafieian-Kopaei M. Bioactive components and preventive effect of green tea (Camellia sinensis) extract on postlaparotomy intra-abdominal adhesion in rats. Int J Surg 2013; 11(9): 811-5.
137. Delfan B, Bahmani M, Rafieian-Kopaei M, Delfan M, Saki K. A review study on ethnobotanical study of medicinal plants used in relief of toothache in Lorestan Province, Iran. Asian Pacific J Trop Dis 2014; 4(Suppl 2): 879-84.
138. Bahmani M, Saki K, Rafieian-Kopaei M, Karamati SA, Eftekhari Z, Jelodari M. The most common herbal medicines affecting Sarcomastigophora branches: a review study. Asian Pacific J Trop Med 2014; 7(Suppl 1): 14-21.